We are live on ! Find out more
ZOM

Zomedica Corp.
ZOM

Delisted

ZOM was delisted on the 4th of March, 2025.

Back to rankings

35 hedge funds and large institutions have $19.5M invested in Zomedica Corp. in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 35 → 35 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

0% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 11

32% less capital invested

Capital invested by funds: $28.6M → $19.5M (-$9.09M)

Holders
35
Holders Change
–
Holders Change %
0%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
11
Reduced
11
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$706K
2
Wells Fargo
Wells Fargo
California
+$106K
3
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
+$67.5K
4
BlackRock
BlackRock
New York
+$63.8K
5
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
+$26.6K

Top Sellers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
-$63.3K
2
Barclays
Barclays
United Kingdom
-$29K
3
Citadel Advisors
Citadel Advisors
Florida
-$25.3K
4
SG Americas Securities
SG Americas Securities
New York
-$24K
5
SPC
Sigma Planning Corp
Michigan
-$20.8K

ZOM Hedge Fund Activity: Q4 2018 in Review

35 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q4 2018, worth a combined $19.5M — down 32% from $28.6M a quarter earlier.

Fund positioning in ZOM was balanced in Q4 2018: 3 funds opened new positions, 3 closed out, 11 added to existing stakes and 11 trimmed.

The largest buyer was State Street, opening a new position worth an estimated $706K. The largest seller was Deutsche Bank, cutting an estimated $63.3K.

  • 35 institutional investors held Zomedica Corp. (ZOM) as of Q4 2018, unchanged from Q3 2018.
  • Funds reported $19.5M of Zomedica Corp. stock for Q4 2018, down 32% quarter-over-quarter.
  • 3 funds opened new Zomedica Corp. positions in Q4 2018 and 3 closed out, a net change of 0 holders.
  • The largest Zomedica Corp. buyer in Q4 2018 was State Street, an estimated $706K added.
  • The largest Zomedica Corp. seller in Q4 2018 was Deutsche Bank, an estimated $63.3K sold.

Based on aggregated 13F filings for Q4 2018.